Serving leading biopharmaceutical companies globally:

Moodys
McKesson
AstraZeneca
McKinsey
Harvard Business School
Express Scripts

Get More Done, Faster

Accurate, objective, and timely intelligence to help you make better decisions

4.3/5 based on G2 reviews

4.4/5 based on Crozdesk reviews

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Solutions designed for all your needs

Reliable primary data + expert analysis. We provide answers for your burning questions

→ See why others have switched

Automated Reports
Stop Wasting Time & Money

How much time are you wasting on repetitive tasks?

DrugPatentWatch can take the load off of your team.

Anticipate Generic Drug Launch
Stop Guessing!

Will a generic version of a drug launch? And when?

Expert analysis based on objective data.

What our Clients Say

❝ I've been using DPW for years and I'm grateful for the responsiveness of the owner, Yali Friedman ❞

❝ I like best … the flexible subscription plans (by module, by month, by year, etc.) ❞

❝ My overall experience with DPW is very positive. The team is generally supportive and their features are growing over time. ❞

❝ Quick and easy to understand summaries, along with all the necessary links for further analysis. ❞

❝ Knowing when drugs are coming off patent and who to contract with has enabled us to stay ahead fo the curve and align ourselves with the proper vendors. ❞

❝ This is a great service with lots of insightful information. ❞

❝ I like the interface, and how it updates with news ❞

❝ Drugpatentwatch is an excellent opportunity for LATAM companies to access information on expired and protected patents from the USA and worldwide in a friendly and easy manner. ❞

Drug Profile

Global Biopharmaceutical Business Intelligence

  • Identify and evaluate commercial opportunities
  • Branded and generic drug pipeline forecasting
  • Anticipate future revenue events
  • Identify API and finished drug product suppliers
Find Generic Drug Entry Opportunities

Find Generic Drug Entry Opportunities

  • Inform portfolio management decisions
  • Sector landscaping and due diligence
  • Track investigational drugs and explore new indications for existing drugs
Drug Patent Litigation

Get Confidential Royalty and Settlement Terms

  • Study failed patent challenges to develop a better strategy
  • Collect competitive intelligence by examining contractual disputes
  • Track litigation to anticipate early generic entry
Drug Prices

Find and Evaluate Business Opportunities

  • Assess levels of generic competition
  • Use drug price ranges to evaluate price elasticity
  • Determine optimal prices before launch
Automated Reports

Automated Reports & Custom Dashboards

  • Do more with less staff
  • Take the load off your team
  • Automate processes and focus on growing your business
Drug Sales Histories and Profiles

Refine Your Market-Entry Strategy

  • Assess market potential through historic sales figures
  • Evaluate buyer power with data on reimbursement segmentation
  • Align distribution methods with information on where and how drugs are purchased
Global Drug Patents in 134 Countries

Global Drug Patents

  • Drug Patents in 134 Countries
  • Evaluate branded and generic market opportunities globally
Track 505(b)(2) entrants

Monitor biosimilar and 505(b)(2) activity

  • Anticipate 505(b)(2) and biosimilar approvals
  • Track OTC-switches, new formulations, biosimilars, and other drug improvements
  • Strengthen new formulation patents by studying prior claims and litigation

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.